{"symbol":"ABBV","fiscalQuarter":"Q2-2025","reportDate":"2025-07-31","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q2-2025","postBrief":{"headline":"AbbVie Misses on EPS, Stock Down 0.15%","keyNumbers":[{"metric":"EPS","actual":"$2.97","expected":"N/A","surprise":"-8.39%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No forward guidance data is available.","changes":[]},"whatItMeans":"AbbVie's earnings report shows a miss on EPS, which may raise concerns among investors about the company's profitability. The stock reacted slightly down by 0.15%, indicating a muted response to the results. Without additional guidance or commentary from management, it remains unclear how the company plans to address these challenges moving forward.","metaDescription":"AbbVie Inc. (ABBV) Q2 2025 earnings: EPS missed expectations. Stock down 0.15%. Full breakdown."}}